These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 14656421

  • 41. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A, Brigante G, Bettaccini AA, Luzzaro F, Grossi P, Toniolo AQ.
    BMC Infect Dis; 2005 Nov 24; 5():106. PubMed ID: 16307682
    [Abstract] [Full Text] [Related]

  • 42. Susceptibility of streptococcus pneumoniae to fluoroquinolones and macrolides in upper respiratory tract infections.
    Mykhalko YO, Duhovych TV, Kish PP.
    Wiad Lek; 2017 Nov 24; 70(2):224-226. PubMed ID: 28511165
    [Abstract] [Full Text] [Related]

  • 43. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus.
    Letrado P, Corsini B, Díez-Martínez R, Bustamante N, Yuste JE, García P.
    Future Microbiol; 2018 Sep 24; 13(11):1215-1223. PubMed ID: 30238774
    [Abstract] [Full Text] [Related]

  • 44. Multidrug-resistant Pneumococcus causing vertebral osteomyelitis.
    Antony SJ.
    J Natl Med Assoc; 1997 Sep 24; 89(9):634-5. PubMed ID: 9302862
    [Abstract] [Full Text] [Related]

  • 45. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model.
    Goldstein BP, Wei J, Greenberg K, Novick R.
    J Antimicrob Chemother; 1998 Aug 24; 42(2):277-8. PubMed ID: 9738856
    [No Abstract] [Full Text] [Related]

  • 46. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R, Ramesh S, Bharathi MJ, Amuthan M, Viswanathan S.
    Indian J Pathol Microbiol; 2010 Aug 24; 53(2):276-80. PubMed ID: 20551532
    [Abstract] [Full Text] [Related]

  • 47. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I, Cars O.
    J Antimicrob Chemother; 2006 Nov 24; 58(5):960-5. PubMed ID: 16936293
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.
    Nicodemo AC, Mendes CM, Oplustil CP, Sinto S.
    Braz J Infect Dis; 2001 Apr 24; 5(2):50-2. PubMed ID: 11493408
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration.
    Fukuda Y, Takahata M, Mitsuyama J.
    J Infect Chemother; 2006 Feb 24; 12(1):1-8. PubMed ID: 16506083
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.